Login to Your Account

Kiniksa makes JPM debut; discloses $80M series A, first asset

By Jennifer Boggs
Managing Editor

Thursday, January 12, 2017

SAN FRANCISCO – For the first time since emerging from stealth mode last year, 2015 startup Kiniksa Pharmaceuticals disclosed its $80 million series A round and introduced the first compound in its pipeline.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription